Archive: 24/03/2015
Gilead's Harvoni accepted in Canadian health plan
Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.
Mar 24, 2015